Physician profile
Vijayasree Arvind
NPI 1104861020
$9,167.66
in general payments reported to CMS, 2019-2025
38 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,270 · 2020: $852 · 2021: $1,245 · 2022: $1,151 · 2023: $1,608 · 2024: $1,858 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,292 · Travel and Lodging: $1,317 · Education: $42.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,292.24 |
| Travel and Lodging | $1,316.63 |
| Education | $42.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $1,640.46 | 2019-2024 | |
| Medtronic, INC. | $1,397.61 | 2021-2023 | Vanta Adaptivestim |
| Nevro Corp. | $905.27 | 2019-2022 | |
| Boston Scientific Corporation | $745.77 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Amgen INC. | $632.47 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $482.38 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $364.57 | 2019-2024 | Ztlido |
| Collegium Pharmaceutical, INC. | $327.34 | 2019-2025 | Belbuca, Xtampza |
| Medtronic USA, INC. | $261.59 | 2019 | |
| Daiichi Sankyo INC. | $256.37 | 2019 | |
| Abbvie INC. | $244.20 | 2021-2024 | Qulipta, Ubrelvy |
| Vertos Medical, INC. | $225.24 | 2021-2023 | Mild Device Kit |
| Spr Therapeutics, INC | $180.47 | 2022-2024 | Sprint Pns System |
| Abbott Laboratories | $170.36 | 2019-2024 | Eterna |
| Lundbeck LLC | $155.00 | 2021-2025 | Vyepti |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vijayasree Arvind listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.